High HIV prevalence and associated factors in Lesotho: Results from a population-based survey.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 07 09 2021
accepted: 01 07 2022
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 2 8 2022
Statut: epublish

Résumé

Despite extensive global efforts, sub-Saharan Africa remains disproportionately affected by the HIV epidemic. This generalized epidemic can be seen in Lesotho which in 2014 the HIV prevalence rate of those aged 15-49 years was 24.6%, with and incidence of 1.9 new infections per 100-person-year exposures. To better understand the impact of Lesotho's national HIV response and significant predictors associated with HIV infection, the Lesotho Population-based HIV Impact Assessment was conducted. This survey provided a nationally representative sample of individuals aged 15-59 years old in which participants were tested for HIV and given an individual questionnaire that included socio-demographic and behavioral risk questions. The association of factors between survey questions and HIV incident was assessed using logistic regression. Multivariate logistic regression models for men and women were constructed for each outcome using variables known to be or plausibly associated with recent or chronic infection. Overall annualized incidence among people aged 15-49 was 1.19% (95% CI 0.73-1.65) per year. The overall prevalence of HIV was 25.6% with women having significantly higher prevalence. Multiple variables, including decreased wealth status, lower education levels, marital status, condom use at first sex, and circumcision (men only) were identified as being significantly associated with HIV infection for both men and women. In combination with improving the awareness of HIV status, an increased focus is needed on AGYW and men 35-49 years old to prevent new infections. HIV education and prevention programs should focus heavily on younger age groups prior to and soon after sexual debut to prevent HIV transmission. The findings of the survey showed significant room for improvement in increasing awareness of HIV status and reinforcing the need for continued HIV prevention and treatment efforts in Lesotho to prevent new infections.

Identifiants

pubmed: 35901094
doi: 10.1371/journal.pone.0271431
pii: PONE-D-21-29030
pmc: PMC9333200
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0271431

Subventions

Organisme : PEPFAR
Pays : United States
Organisme : CGH CDC HHS
ID : U2G GH001226
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet HIV. 2019 Sep;6(9):e613-e622
pubmed: 31422056
AIDS Care. 2009 Jan;21(1):87-93
pubmed: 19085224
AIDS Behav. 2017 Sep;21(9):2579-2588
pubmed: 28058565
HIV AIDS (Auckl). 2013 May 24;5:97-109
pubmed: 23737677
BMC Med. 2013 Oct 16;11:224
pubmed: 24131484
AIDS. 2016 Nov 13;30(17):2685-2695
pubmed: 27782965
PLoS One. 2016 Jan 25;11(1):e0147828
pubmed: 26808547
Afr J Reprod Health. 2013 Jun;17(2):46-57
pubmed: 24069751
Open AIDS J. 2016 Apr 08;10:34-48
pubmed: 27347270
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
Sex Transm Infect. 2007 Aug;83 Suppl 1:i50-54
pubmed: 17314125
Int Fam Plan Perspect. 2006 Jun;32(2):79-88
pubmed: 16837388
N Engl J Med. 2000 Mar 30;342(13):921-9
pubmed: 10738050
AIDS. 2017 Jun 19;31(10):1461-1470
pubmed: 28426534
Clin Infect Dis. 2018 Jun 1;66(12):1846-1857
pubmed: 29272346
SSM Popul Health. 2021 May 29;15:100833
pubmed: 34141854
AIDS. 2020 Jan 1;34(1):149-154
pubmed: 31483373
MMWR Morb Mortal Wkly Rep. 2017 Aug 04;66(30):813-814
pubmed: 28771456
AIDS. 2010 Mar 13;24(5):737-44
pubmed: 20042848
AIDS Behav. 2016 Jan;20(1):65-70
pubmed: 25771909
Clin Infect Dis. 2021 Aug 16;73(4):594-604
pubmed: 33912973
Sex Transm Infect. 2009 Apr;85 Suppl 1:i1-2
pubmed: 19307334
J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):620-4
pubmed: 20980913
Afr Health Sci. 2013 Jun;13(2):407-14
pubmed: 24235943
AIDS Res Ther. 2013 Dec 13;10(1):30
pubmed: 24330537
Health Educ Res. 2016 Apr;31(2):260-72
pubmed: 26956041
PLoS One. 2017 Oct 12;12(10):e0186316
pubmed: 29023510
AIDS. 2019 Dec 1;33(15):2393-2401
pubmed: 31764104
PLoS One. 2017 May 12;12(5):e0177076
pubmed: 28498835

Auteurs

Amee Schwitters (A)

Centers for Disease Control and Prevention, Maseru, Lesotho.

Stephen McCracken (S)

Division of Global HIV and TB, US Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, United States of America.

Koen Frederix (K)

ICAP in Lesotho, Mailman School of Public Health, Columbia University, Maseru, Lesotho.

Reese Tierney (R)

School of Public Health at Georgia State University, Atlanta, GA, United States of America.

Masebeo Koto (M)

Lesotho Ministry of Health, Maseru, Lesotho.

Nahima Ahmed (N)

ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, United States of America.

Kyaw Thin (K)

Lesotho Ministry of Health, Maseru, Lesotho.

Trudy Dobbs (T)

ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, United States of America.

Sakhile Sithole (S)

ICAP in Lesotho, Mailman School of Public Health, Columbia University, Maseru, Lesotho.

Mosilinyane Letsie (M)

Lesotho Ministry of Health, Maseru, Lesotho.

Bharat Parekh (B)

Division of Global HIV and TB, US Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, United States of America.

Hetal Patel (H)

Division of Global HIV and TB, US Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, United States of America.

Sehin Birhanu (S)

Division of Global HIV and TB, US Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, United States of America.

Lubbe Wiesner (L)

Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

Andrea Low (A)

ICAP at Columbia University, Mailman School of Public Health, Columbia University, New York, NY, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH